Nisar, Muhammad Imran
Kabole, Ibrahim
Khanam, Rasheda
Shahid, Shahira
Bakari, Bihila Abdalla
Chowdhury, Nabidul Haque
Qazi, Muhammad Farrukh
Dutta, Arup
Rahman, Sayedur
Khalid, Javairia
Dhingra, Usha
Hasan, Tarik
Ansari, Nadia
Deb, Saikat
Mitra, Dipak K.
Mehmood, Usma
Aftab, Fahad
Ahmed, Salahuddin
Khan, Shahiryar
Ali, Said Mohammad
Ahmed, Saifuddin
Manu, Alexander
Yoshida, Sachiyo
Bahl, Rajiv
Baqui, Abdullah H.
Sazawal, Sunil
Jehan, Fyezah
Funding for this research was provided by:
Bill and Melinda Gates Foundation (I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438, I64438)
Article History
Received: 16 February 2024
Accepted: 12 June 2024
First Online: 29 June 2024
Declarations
:
: The AMANHI study received ethical approval from the local and institutional ethics committees of all the three sites. These included Zanzibar Health Research Ethics Committee (formerly ZAMREC) (ZAMREC/0002/OCTOBER/013) for Tanzania, ICDDR, B (PR12073) and John Hopkins University (IRB 00004508) for Bangladesh and Aga Khan University (2790-paeds-ERC-13) for Pakistan. In addition, the protocols for the biorepository study were also approved by the WHO Ethics Review Committee (RPC 532) and continuing approvals were sought yearly. Written informed consent was obtained from study participants in which all study and sample handling and study procedures were explained in detail.
: Not Applicable.
: The authors declare no competing interests.